AKAP1 and gastric cancer: Interestingly, in a recent report about cisplatin resistance in gastric cancer, the authors discovered that the microRNA miR-148a-3p directly targets AKAP1 and leads to greater Drp1 activation, which sensitizes cancer cells to cisplatin treatment.